Skip to content

Drug interactions

Nilotinib + Sorafenib

Severity: Major

Nilotinib and Sorafenib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QT interval, so combined use may increase the chance of ventricular arrhythmias including torsades de pointes. Risk is higher with electrolyte disturbances.

What this interaction means in plain words

Nilotinib and Sorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Nilotinib belongs to Oncology; Sorafenib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic QT interval prolongation.

What to do

Obtain a baseline ECG and monitor QTc periodically, and keep potassium and magnesium normal. Avoid additional QT-prolonging drugs.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nilotinib and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nilotinib with Sorafenib?

MediHelp rates the interaction as major. Nilotinib and Sorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs can prolong the QT interval, so combined use may increase the chance of ventricular arrhythmias including torsades de pointes. Risk is higher with electrolyte disturbances.

How serious is the interaction between Nilotinib and Sorafenib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor QTc periodically, and keep potassium and magnesium normal. Avoid additional QT-prolonging drugs.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in